Facility in Gliwice, Poland to spice up biopharma producers’ potency and velocity to marketplace of treatments
RADNOR, Pa., March 17, 2025 /PRNewswire/ — Avantor, Inc. (NYSE: AVTR), a eminent world supplier of mission-critical services within the existence sciences and complicated generation industries, publicizes that Ger Brophy, PhD, head of Avantor’s Clinical Advisory Board, will provide highlights of the lately finished enlargement at its flagship Eu production web page at Drug, Chemical & Related Applied sciences Affiliation (DCAT) Week 2025. Dr. Brophy’s presentation will rush park as a part of the Member Corporate Announcement Discussion board on Monday, March 17, at roughly 9:15 am jap. DCAT Hour, which runs March 17 – 20 in Unused York Town, is the premier annual match for firms i’m busy within the International Bio/Pharmaceutical Production Price Chain.
The untouched manufacturing facility’s complicated applied sciences quadruple the web page’s capability for production, formulating, and filling United States Pharmacopoeia (USP) purified aqua and Aqua for Injection (WFI)-based hydration answers. Those high-purity answers are crucial in buffer arrangements, cellular tradition media, clean-in-process (CIP), and method processes, supporting the steadiness, efficacy, and protection of biologics and alternative life-saving treatments.
“This latest investment strengthens our global manufacturing network, building important capacity and bringing our operations closer to customers,” mentioned Benoit Gourdier, EVP of Avantor’s Bioscience Manufacturing Area. “It ensures a dependable supply of high-quality products while strengthening our role as a trusted partner, working alongside biopharma manufacturers to produce life changing therapies.”
Lately, Avantor has made considerable investments to make stronger world manufacturing capability and introduce untouched merchandise to provide the rising bioprocessing wishes of drug producers. This venture in Poland builds on a up to date enlargement on the Aurora, Ohio production web page, which added important hydrated answers capability to help the North American marketplace. Moreover, a untouched manufacturing facility on the Phillipsburg, N.J. production web page has doubled the output of synthesized salts, a very important factor in hydration production. Those investments support Avantor’s world manufacturing potency, optimize provide chain operations and enhance the provision of uncooked fabrics for biopharma programs to consumers international.
Along with expanding production capability, Avantor has additionally expanded its analysis and innovation functions. In November 2024, the corporate opened its untouched 60,000-square-foot Bridgewater Innovation Middle in Unused Jersey doubling its earlier lab and pilot plant capability, improving collaboration and bioprocessing innovation. Designed for upstream and downstream building, analytical checking out, and viral vector analysis, the cutting-edge facility speeds up scale-up and customization throughout all of the bioprocessing workflow.
About Avantor
Avantor® is a eminent existence science gear corporate and world supplier of mission-critical services to the existence sciences and complicated generation industries. We paintings side-by-side with consumers at each and every step of the medical proceed to permit breakthroughs in drugs, healthcare, and generation. Our portfolio is impaired in just about each and every degree of probably the most noteceable analysis, building, and manufacturing actions at greater than 300,000 buyer places in 180 international locations. For more info, seek advice from avantorsciences.com and in finding us on LinkedIn, X (Twitter), and Fb.
International Media Touch
Eric Van Zanten
Head of Exterior Communications
Avantor
610-529-6219
[email protected]
Investor Members of the family Touch
Allison Hosak
Senior Vice President, International Communications
Avantor
908-329-7281
[email protected]
SOURCE Avantor and Monetary Information
